ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2020

Implementation of Empagliflozin in Patients with Diabetes Mellitus Type 2 and Established Cardiovascular Disease: Estimation of 5-Year Survival and Costs in Sweden.

Lars Bernfort et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.